219 related articles for article (PubMed ID: 12818576)
1. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
Nakagami H; Takemoto M; Liao JK
J Mol Cell Cardiol; 2003 Jul; 35(7):851-9. PubMed ID: 12818576
[TBL] [Abstract][Full Text] [Related]
2. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK
J Clin Invest; 2001 Nov; 108(10):1429-37. PubMed ID: 11714734
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
Li L; Zhang ZG; Lei H; Wang C; Wu LP; Wang JY; Fu FY; Zhu WG; Wu LL
PLoS One; 2013; 8(1):e49915. PubMed ID: 23349663
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes.
Laskowski A; Woodman OL; Cao AH; Drummond GR; Marshall T; Kaye DM; Ritchie RH
Cardiovasc Res; 2006 Oct; 72(1):112-23. PubMed ID: 16890211
[TBL] [Abstract][Full Text] [Related]
5. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Zhang Q; Tan Y; Zhang N; Yao F
Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
[TBL] [Abstract][Full Text] [Related]
6. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
Custodis F; Eberl M; Kilter H; Böhm M; Laufs U
Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001
[TBL] [Abstract][Full Text] [Related]
7. Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.
Hou N; Cai B; Ou CW; Zhang ZH; Liu XW; Yuan M; Zhao GJ; Liu SM; Xiong LG; Luo JD; Luo CF; Chen MS
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):535-545. PubMed ID: 28210753
[TBL] [Abstract][Full Text] [Related]
8. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
Gang C; Qiang C; Xiangli C; Shifen P; Chong S; Lihong L
J Pharm Pharm Sci; 2015; 18(2):235-48. PubMed ID: 26158288
[TBL] [Abstract][Full Text] [Related]
9. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
10. LRRC8A contributes to angiotensin II-induced cardiac hypertrophy by interacting with NADPH oxidases via the C-terminal leucine-rich repeat domain.
Huo C; Liu Y; Li X; Xu R; Jia X; Hou L; Wang X
Free Radic Biol Med; 2021 Mar; 165():191-202. PubMed ID: 33515753
[TBL] [Abstract][Full Text] [Related]
11. Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Fu M; Zhang J; Xu S; Pang Y; Liu N; Tang C
Chin Med Sci J; 2001 Mar; 16(1):1-4. PubMed ID: 12899339
[TBL] [Abstract][Full Text] [Related]
12. Requirement of Rac1 in the development of cardiac hypertrophy.
Satoh M; Ogita H; Takeshita K; Mukai Y; Kwiatkowski DJ; Liao JK
Proc Natl Acad Sci U S A; 2006 May; 103(19):7432-7. PubMed ID: 16651530
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells.
Laplante MA; Wu R; El Midaoui A; de Champlain J
J Hypertens; 2003 May; 21(5):927-36. PubMed ID: 12714867
[TBL] [Abstract][Full Text] [Related]
14. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
15. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
[TBL] [Abstract][Full Text] [Related]
16. Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species.
Liu J; Zhou J; An W; Lin Y; Yang Y; Zang W
Can J Physiol Pharmacol; 2010 Jul; 88(7):745-52. PubMed ID: 20651822
[TBL] [Abstract][Full Text] [Related]
17. Ca
Zhao GJ; Zhao CL; Ouyang S; Deng KQ; Zhu L; Montezano AC; Zhang C; Hu F; Zhu XY; Tian S; Liu X; Ji YX; Zhang P; Zhang XJ; She ZG; Touyz RM; Li H
Hypertension; 2020 Sep; 76(3):827-838. PubMed ID: 32683902
[TBL] [Abstract][Full Text] [Related]
18. The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.
Liu K; Deng X; Gong L; Chen X; Wang S; Chen H; Chen X; Amrit B; He S
Clin Lab; 2013; 59(5-6):589-96. PubMed ID: 23865358
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Attenuates Thyroid Hormone-Induced Cardiac Hypertrophy in Rats by regulating angiotensin II type 1 receptor and NADPH oxidase 2 mediated oxidative stress.
Yang H; Bai J; Zhan C; Liu S; Gao Y; Zhong L; Lv Y; Chi J; Liu J; Yang X; Yang W
Eur J Pharmacol; 2022 May; 922():174917. PubMed ID: 35341785
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases.
Zhang H; Schmeisser A; Garlichs CD; Plötze K; Damme U; Mügge A; Daniel WG
Cardiovasc Res; 1999 Oct; 44(1):215-22. PubMed ID: 10615405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
